CSIMarket


Ge Healthcare Technologies Inc   (GEHC)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare

Ge Healthcare Technologies Inc

GEHC's Fundamental analysis








Looking into Ge Healthcare Technologies Inc growth rates, revenue grew by 0.57 % in II. Quarter 2024 from the same quarter a year ago. Ranking at No. 1617

Medical Laboratories industry recorded growth of revenues by 0.86 %

Ge Healthcare Technologies Inc 's net income grew by 0.46 % in II. Quarter 2024 year on year, above company average,

More on GEHC's Growth


Ge Healthcare Technologies Inc
current PE on trailing twelve month basis is above Medical Laboratories industry average.

Company is currently trading with Price to Cash flow multiple of 576.08 in trailing twelve-month period.
Company
26.65
PE TTM   
Industry
-0
PE TTM    
Company's Price to Sales ratio is at 2.57.
Medical Laboratories industry's Price to Sales ratio is at 3.22.


More on GEHC's Valuation
 
 Total Debt (Millions $) 9,240
 Dividend TTM ($) 0.12 $
 Dividend Yield TTM (%) 0.13 %
 Revenue/Employee (TTM) $ 327,020
 Net Income/Employee (TTM) $ 32,420
 Receivable Turnover (TTM) 4.82
 Tangible Book Value (Per Share $) -14.15

Ge Healthcare Technologies Inc
current PE on trailing twelve month basis is above Medical Laboratories industry average.

Company is currently trading with Price to Cash flow multiple of 576.08 in trailing twelve-month period.
Company
26.65
PE TTM   
Industry
-0
PE TTM    
Company's Price to Sales ratio is at 2.57.
Medical Laboratories industry's Price to Sales ratio is at 3.22.

Ge Healthcare Technologies Inc Price to Book Ratio is at 5.38 lower than Industry Avg. of 409.08. and higher than S&P 500 Avg. of 0

More on GEHC's Valuation

  Market Capitalization (Millions $) 42,054
  Shares Outstanding (Millions) 459
  Employees 50,000
  Revenues (TTM) (Millions $) 16,351
  Net Income (TTM) (Millions $) 1,621
  Cash Flow (TTM) (Millions $) 73
  Capital Exp. (TTM) (Millions $) -383
  Total Debt (Millions $) 9,240
  Dividend TTM ($) 0.12 $
  Dividend Yield TTM (%) 0.13 %
  Revenue/Employee (TTM) $ 327,020
  Net Income/Employee(TTM) $ 32,420
  Receivable Turnover Ratio (TTM) 4.82
  Tangible Book Value (Per Share $) -14.15

  Market Capitalization (Millions $) 42,054
  Shares Outstanding (Millions) 459
  Employees 50,000
  Revenues (TTM) (Millions $) 16,351
  Net Income (TTM) (Millions $) 1,621
  Cash Flow (TTM) (Millions $) 73
  Capital Exp. (TTM) (Millions $) -383


    GEHC's Profitability Comparisons
Ge Healthcare Technologies Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in II. Quarter 2024 to 15.02 % from 13.96 % in I. Quarter.

Ge Healthcare Technologies Inc net profit margin of 10.75 % is currently ranking no. 6 in Medical Laboratories industry, ranking no. 81 in Healthcare sector and number 1079 in S&P 500.


Profitability by Segment
Total 10.75 %



  Ratio
   Capital Ratio (MRQ) 1.06
  Total Debt to Equity (MRQ) 1.18
  Tangible Leverage Ratio (MRQ) -
  Asset Turnover Ratio (TTM) 0.57
  Inventory Turnover Ratio (TTM) 4.13



Ge Healthcare Technologies Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in II. Quarter 2024 to 15.02 % from 13.96 % in I. Quarter.

Ge Healthcare Technologies Inc net profit margin of 10.75 % is currently ranking no. 6 in Medical Laboratories industry, ranking no. 81 in Healthcare sector and number 1079 in S&P 500.

More on GEHC's Key Ratios





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com